Company profile for Pharma Two B

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Pharma Two B is a clinical-stage pharmaceutical company developing novel, synergistic, combination products based on previously approved drugs. We refined our years of expertise to identify and characterize potential drug combinations that can offer high therapeutic effects with improved safety profiles. Our goal is to develop clinically meaningful, safe and commercially added-value combination products to address unmet medica...
Pharma Two B is a clinical-stage pharmaceutical company developing novel, synergistic, combination products based on previously approved drugs. We refined our years of expertise to identify and characterize potential drug combinations that can offer high therapeutic effects with improved safety profiles. Our goal is to develop clinically meaningful, safe and commercially added-value combination products to address unmet medical needs and decreased timelines to FDA approval via the (US 505(b)(2)) regulatory pathway.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Israel
Address
Address
3 Pekeris Street, Weizmann Science Park, Rehovot, 7670203
Telephone
Telephone
+972-8-9472672
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/reverse-reverse-liver-disease-biotech-hepion-and-pharma-two-b-call-merger

FIERCE BIOTECH
11 Dec 2024

https://www.globenewswire.com/news-release/2024/12/05/2992326/0/en/Pharma-Two-B-Announces-Poster-Presentation-on-P2B001-at-the-Annual-Meeting-of-the-Parkinson-s-Disease-Study-Group.html

GLOBENEWSWIRE
05 Dec 2024

https://www.globenewswire.com/news-release/2024/11/11/2978264/0/en/Pharma-Two-B-and-Hepion-Pharmaceuticals-Inc-Announce-Effectiveness-of-Registration-Statement-Related-to-Proposed-Merger.html

GLOBENEWSWIRE
11 Nov 2024

https://www.globenewswire.com/news-release/2024/09/04/2940630/0/en/Pharma-Two-B-and-Hepion-Pharmaceuticals-Inc-Announce-Filing-of-Registration-Statement-on-Form-F-4-Related-to-Proposed-Merger.html

GLOBENEWSWIRE
04 Sep 2024

https://www.globenewswire.com/news-release/2022/09/15/2516777/0/en/Pharma-Two-B-Presents-Positive-Efficacy-and-Safety-Data-of-P2B001-from-Phase-3-Trial-at-the-MDS-International-Congress-of-Parkinson-s-Disease-and-Movement-Disorders.html

GLOBENEWSWIRE
15 Sep 2022

https://www.globenewswire.com/news-release/2022/04/05/2416529/0/en/Pharma-Two-B-Presents-Late-Breaker-Abstract-on-Positive-Efficacy-and-Safety-Data-of-P2B001-from-Phase-3-Trial-at-American-Academy-of-Neurology-AAN-Annual-Meeting.html

GLOBENEWSWIRE
05 Apr 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty